Status:

COMPLETED

Bicarbonate Administration in Kidney Transplant Recipients

Lead Sponsor:

University of Colorado, Denver

Conditions:

Kidney Transplant; Complications

Metabolic Acidosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Metabolic acidosis is associated with vascular endothelial dysfunction and is a common complication in patients who have received a kidney transplant. Kidney transplant recipients (KTR) with lower ser...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Kidney transplant received at least 1 year ago
  • Serum bicarbonate 20-26 mEq/L on 2 separate measurements (at least 1 day apart)
  • eGFR \>45 ml/min/1.73m2
  • Blood pressure \<140/90 mm Hg prior to randomization
  • BMI \< 40 kg/m2 (FMD measurements can be inaccurate in severely obese patients).
  • Able to provide consent
  • Stable kidney transplant medication regimen for at least 1 month prior to randomization
  • Stable anti-hypertensive regimen for at least one month prior to randomization
  • Not taking medications that interact with agents administered during experimental sessions (e.g. sildenafil interacts with nitroglycerin).

Exclusion

  • Significant comorbid conditions that lead the investigator to conclude that life expectancy is less than 1 year
  • Use of chronic daily oral alkali within the last 3 months (including sodium bicarbonate, calcium carbonate or baking soda)
  • Uncontrolled hypertension
  • Serum potassium \< 3.3 or ≥ 5.5 mEq/L at screening
  • New York Heart Association Class 3 or 4 heart failure symptoms, known EF ≤30%, or hospital admission for heart failure within the past 3 months · Factors judged to limit adherence to interventions
  • Current participation in another research study
  • Pregnancy or planning to become pregnant or currently breastfeeding
  • Chronic use of supplemental oxygen

Key Trial Info

Start Date :

December 5 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 25 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03428464

Start Date

December 5 2018

End Date

March 25 2020

Last Update

October 22 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Colorado Hospital

Aurora, Colorado, United States, 80045